Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Metformin Intolerance
NCT03361878Phase 4Completed
- Sponsor
- NHS Tayside
- Start
- May 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by NHS Tayside. Primary endpoint: Metformin Area Under the Curve at 24 hours. Started May 2014; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03361878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03361878.